Adjuvants that enhance Th2 or Tr responses

Allergology International

Volumn 54, Issue 4, 2005, Pages 507-513

  Matsushita, Sho ^a   Liu, Tianyi ^a   Wakui, Masatoshi ^a   Uemura, Yasushi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adjuvants; Allergy; Dendritic cells; HLA; Notch ligands; Th2; Toll like receptors

Indexed keywords

ADJUVANT; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 4; LIGAND; NOTCH RECEPTOR; PHOSPHATIDYLSERINE; PHOSPHOLIPID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ALLERGY; CD4+ T LYMPHOCYTE; CELL MEMBRANE; DENDRITIC CELL; ENDOSOME; MAGNETIC SEPARATION; PARASITE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH2 CELL;

EID: 33846795897     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.54.507     Document Type: Review

References (28)

1. Takeda K, Akira S. Toll receptors and pathogen resistance. Cell Microbiol. 2003;5:143-153.
2. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002;20:709-760.
3. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 2002;293:1364-1369.
4. Fitzgerald KA, Palsson-McDermott EM, Bowie AG et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001;413:78-83.
5. Ozinsky A, Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 2000;97:13766-13771.
6. Whelan M, Harnett MM, Houston KM, Patel V, Harnett W, Ringley KP. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J. Immunol. 2000;164:6453-6460.
7. van der Kleij D, Latz E, Brouwers JFHM et al. A novel host-parasite lipid cross-talk. J. Biol. Chem. 2002;50:48122- 48129.
8. van der Kleij D, Yazdanbakhsh M. Control of inflammatory diseases by pathogens: lipids and the immune system. Eur. J. Immunol. 2003;33:2953-2963.
9. Redecke V, Haecker H, Datta SK et al. Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 2004;172:2739-2743.
10. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. Control of Th2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000;404:407-411.
11. Kalinski P, Vieira PL, Schuitemaker JHN, de Jong EC, Kapsenberg ML. Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 2001;97:3466-3469.
12. Traidl-Hoffmann C, Kasche A, Menzel A et al. Impact of pollen on human health: More than allergen carriers? Int. Arch. Allergy Immunol. 2003;131:1-13.
13. Agrawal S, Agrawal A, Doughty B et al. Different toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen- activated protein kinase and c-Fos. J. Immunol. 2003;171:4984- 4989.
14. Coker HA, Durham SR, Gould HJ. Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J. Immunol. 2003;171:5602-5610.
15. Soumelis V, Reche PA, Kanzler H et al. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nature Immunol. 2002;3:673-680.
16. Matsuoka T, Tabata H, Matsushita S. Monocytes are differentially activated through HLA-DR, -DQ and -DP molecules via MAP kinases. J. Immunol. 2001;166:2202-2208.
17. Matsushita S, Liu T-Y, Ohyama H, Uemura Y. Signal transduction through HLA-DQ molecules alter dendritic cell function to enhance Th2 differentiation. EAACI;2004, Amsterdam (abstract).
18. Hirayama K, Matsushita S, Kikuchi I, Iuchi M, Ohta N, Sasazuki T. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 1987;327:426-430.
19. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-776.
20. Maillard I, Adler SH, Pear WS. Notch and the immune system. Immunity 2003;19:781-791.
21. Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. Instruction of CD4 T helper cell fates by different Notch ligands on antigen-presenting cells. Cell 2004;117:515-526.
22. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 2002;196:1645- 1651.
23. Kaisho T, Hoshino K, Iwabe T, Takeuchi O, Yasui T, Akira S. Endotoxin can induce Myd88-deficient dendritic cells to support T (h) 2 cell differentiation. Int. Immunol. 2002;14:695-700.
24. Maekawa Y, Tsukumo S, Chiba S et al. Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 2003;19:549-559.
25. de La Coste A, Six E, Fazilleau N et al. In vivo and in absence of a thymus, the enforced expression of the Notch ligands Delta-1 or Delta-4 promotes T cell development with specific unique effects. J. Immunol. 2005;174:2730-2737.
26. Hoyne GF, Le Roux I, Corsin-Jimenez M et al. Serrate 1-induced notch signaling regulates the decision between immunity and tolerance made by peripheral CD4(+)T cells. Int. Immunol. 2000;12:177-185.
27. Vigouroux S, Yvon E, Wagner HJ et al. Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes. J. Virol. 2003;77:10872-10880.
28. Yvon ES, Vigouroux S, Rousseau RF et al. Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. Blood 2003;102:3815-3821.